Tag Archives: s. 101

Senate Subcommittee on IP Feels our PAIN

Posted on June 6, 2019 by Warren Woessner

In lengthy hearings conducted by the Senate Subcommittee on Intellectual Property (of the Committee on the Judiciary) on June 4th and 5th (Parts I and II; Part III will be held on June 11th), the Subcommittee, chaired by Senators Tillis … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Senate Committee Releases Outline for Section 101 Reform

Posted on April 18, 2019 by Warren Woessner

On April 18th, the Senate Judiciary Subcommittee on Intellectual Property released a “Draft Outline of Section 101 Reform” that is intended to provide the basis of legislative amendments to the requirements for patent reform. Apart from the proposal to effectively … Continue reading →

Posted in Patent Eligible Subject Matter, Patent Reform Legislation | Tagged , , , , , , | Leave a comment

Athena’s Petition for Rehearing En Banc – Not All Diagnostic Claims are Equal Under s. 101

Posted on April 15, 2019 by Warren Woessner

In my last post on s. 101, discussing “Cleveland Clinic II” I asked, “Why can’t a diagnostic conclusion be a practical application of a natural law?” and rhetorically answered: “Because the Federal Circuit says it can’t.” In Cleveland Clinic I … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

Top Ten List of Patent News Stories in 2018

Posted on December 31, 2018 by Warren Woessner

Although this list will reach most the readers of Patents4Life after 2019 begins, 2018 deserves some attention even if it has the feel of “those we lost in 2018” lists. Although most of my colleague-commentators have published their lists by … Continue reading →

Posted in 2018 Patent News, Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , , , , | Leave a comment